Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-07 07:17 am Sale | 2026-09-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Federated Hermes, Inc. FHI | 1,678,069 5.900% | -1,625,571 (-49.21%) | Filing History |
| 2026-05-07 3:37 pm Purchase | 2026-04-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,947,556 10.370% | 336,457 (+12.89%) | Filing History |
| 2026-03-26 3:56 pm Sale | 2026-03-13 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 0 0.000% | -1,810,165 (Position Closed) | Filing History |
| 2026-02-17 06:49 am Sale | 2025-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BALYASNY ASSET MANAGEMENT L.P. | 0 0.000% | -2,183,985 (Position Closed) | Filing History |
| 2026-02-03 11:27 am Purchase | 2025-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,611,099 9.190% | 896,059 (+52.25%) | Filing History |
| 2026-01-08 08:12 am Sale | 2025-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Federated Hermes, Inc. FHI | 3,303,640 11.630% | -1,407,872 (-29.88%) | Filing History |
| 2025-11-14 06:02 am Purchase | 2025-09-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BALYASNY ASSET MANAGEMENT L.P. | 2,183,985 8.040% | 2,183,985 (New Position) | Filing History |
| 2025-11-13 09:24 am Purchase | 2025-09-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Amova Asset Management Americas Inc. | 1,947,835 7.200% | 21,751 (+1.13%) | Filing History |
| 2025-10-27 06:57 am Purchase | 2025-09-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Sumitomo Mitsui Trust Group Inc. | 1,947,835 7.200% | 21,751 (+1.13%) | Filing History |
| 2025-07-30 1:16 pm Sale | 2025-06-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 1,715,040 6.320% | -332,647 (-16.25%) | Filing History |
| 2025-07-29 12:05 pm Purchase | 2025-06-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 1,810,165 6.670% | 351,785 (+24.12%) | Filing History |
| 2025-05-12 2:10 pm Sale | 2025-03-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Amova Asset Management Americas Inc. | 1,926,084 7.100% | -389,210 (-16.81%) | Filing History |
| 2025-04-25 06:18 am Sale | 2025-03-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Sumitomo Mitsui Trust Group Inc. | 1,926,084 7.100% | -389,210 (-16.81%) | Filing History |
| 2025-04-23 8:14 pm Sale | 2025-03-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BlackRock, Inc. BLK | 2,104,537 7.800% | -638,465 (-23.28%) | Filing History |
| 2025-02-05 07:52 am Sale | 2024-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | STATE STREET CORPORATION STT | 1,326,158 4.900% | -303,508 (-18.62%) | Filing History |
| 2024-11-08 3:17 pm Purchase | 2024-09-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Amova Asset Management Americas Inc. | 2,315,294 8.560% | 994,642 (+75.31%) | Filing History |
| 2024-11-05 06:07 am Purchase | 2024-09-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Sumitomo Mitsui Trust Group Inc. | 2,315,294 8.560% | 994,642 (+75.31%) | Filing History |
| 2024-04-05 12:18 pm Purchase | 2024-03-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BlackRock, Inc. BLK | 2,743,002 10.200% | 344,706 (+14.37%) | Filing History |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 1,458,380 5.460% | 7,955 (+0.55%) | Filing History |
| 2024-02-12 6:09 pm Sale | 2023-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Amova Asset Management Americas Inc. | 1,320,652 4.940% | -128,408 (-8.86%) | Filing History |